WHO lists 'Disease X' among priority diseases: Report

Image
IANS Geneva
Last Updated : Mar 13 2018 | 2:25 PM IST

The World Health Organization (WHO) has listed "Disease X", which could potentially trigger deadly global epidemic in the near future, among priority diseases, calling for urgent measures to accelerate research and development to tackle it.

"Disease X" was listed in the 2018 annual review of R&D Blueprint, a list developed by the WHO to identify, prioritise and accelerate research and development for diseases that lack efficacious drugs and/or vaccines, and pose public health risk.

"Disease X represents the knowledge that a serious international epidemic could be caused by a pathogen currently unknown to cause human disease," WHO said in a statement late Monday.

Thus, the new report "explicitly seeks to enable cross-cutting research and development preparedness that is also relevant for an unknown 'Disease X' as far as possible".

Besides Disease X, the seven other potential global disease threats each lacking an effective drug or vaccine includes Crimean-Congo hemorrhagic fever (CCHF); Ebola virus disease and Marburg virus disease; Lassa fever; Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS); Nipah and henipaviral diseases Rift Valley fever (RVF); and Zika.

These diseases pose major public health risks and further research and development is needed, including surveillance and diagnostics.

They should be watched carefully and considered again at the next annual review. Efforts in the interim to understand and mitigate them are encouraged, the statement said.

Outside the 2018 Blueprint, the WHO also mentioned dengue, yellow fever, HIV/AIDs, tuberculosis, malaria, influenza causing severe human disease, smallpox, cholera, leishmaniasis, West Nile Virus and plague, saying further research and development is needed to tackle these diseases.

--IANS

rt/ksk/nir

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 13 2018 | 2:16 PM IST

Next Story